Correction: Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells.
Main Authors: | Barend Andre Stander, Fourie Joubert, Chingkuang Tu, Katherine H. Sippel, Robert McKenna, Annie Margaretha Joubert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3790890 |
Similar Items
-
Signaling pathways of ESE-16, an antimitotic and anticarbonic anhydrase estradiol analog, in breast cancer cells.
by: Barend Andre Stander, et al.
Published: (2013-01-01) -
Correction: Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells
by: Barend Andre Stander, et al.
Published: (2013-01-01) -
In vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activity.
by: Barend Andre Stander, et al.
Published: (2012-01-01) -
Synergistic Anticancer Potential of Dichloroacetate and Estradiol Analogue Exerting their Effect via ROS-JNK-Bcl-2-Mediated Signalling Pathways
by: Xiao Xing Stander, et al.
Published: (2015-03-01) -
Dysregulation of Catalase by a Sulphamoylated Estradiol Analogue Culminates in Antimitotic Activity and Cell Death Induction in Breast Cancer Cell Lines
by: Maphuti T. Lebelo, et al.
Published: (2021-01-01)